Imidazolinone and hydantoine derivatives as novel inhibitors of histone deacetylase

Details for Australian Patent Application No. 2006260961 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Ten Holte, Peter; Angibaud, Patrick Rene; Marconnet-Decrane, Laurence Francoise Bernadette; Meerpoel, Lieven; Van Emelen, Kristof

Agent Shelston IP

Pub. Number AU-B-2006260961

PCT Pub. Number WO2006/136553

Priority 05105592.9 23.06.05 EP

Filing date 20 June 2006

Wipo publication date 28 December 2006

Acceptance publication date 11 August 2011

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4166 (2006.01)

A61P 35/00 (2006.01) Antineoplastic agents

C07D 413/14 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

Event Publications

31 January 2008 PCT application entered the National Phase

  PCT publication WO2006/136553 Priority application(s): WO2006/136553

11 August 2011 Application Accepted

  Published as AU-B-2006260961

8 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006260969-1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) - 3-substituted-1,3-dihydro-benzoimidazo l-2-ones with activity on respiratory syncytial virus

2006260960-Process for the production of intermadiates for the preparation of tricyclic benzimidazoles